PVSH A/S: Financial statements 2012
CVR: 21653934
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
PVSH A/S (CVR 21653934) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK -540,431 and a net result of DKK 46,981,956. Equity in the 2012 report amounted to DKK 19,853,164. The solvency ratio was 99%.
- Gross Profit
- DKK -540,431
- Profit/Loss
- DKK 46,981,956
- Equity
- DKK 19,853,164
- Total Assets
- DKK 20,054,341
Official annual report
Keep an eye on PVSH A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of December 1, 2012, Anders Kristian Worsøe is registered as adm. dir of PVSH A/S.
As of December 1, 2012, Klaus Baagøe-Nielsen has stepped down as adm. dir of PVSH A/S.
On February 27, 2012, the company changed its name from PHARMA-VINCI SCANDINAVIA HOLDING A/S to PVSH A/S.
As of February 15, 2012, Grant Thornton, Godkendt Revisionspartnerselskab has been appointed auditor of PVSH A/S.
As of February 15, 2012, DKNF 387 ApS has stepped down as auditor of PVSH A/S.
About PVSH A/S
PVSH A/S was a Danish company of the type Aktieselskab based in København K, founded in 1999. The company has been dissolved on 30 May 2018. The company was registered under the industry Ikke-finansielle holdingselskaber. The company was previously named PHARMA-VINCI SCANDINAVIA HOLDING A/S. The company has 1 employee (2012). In 2016, the company reported a gross profit of DKK -76,094 and a net result of DKK 467,229 compared with DKK -258,559 the year before. Equity in the 2016 report amounted to DKK 553,281.